Zhejiang Realsun Chemical Co., Ltd. Class A

Zhejiang Realsun Chemical Co., Ltd. Class A

SSZSE:301212
19.86
CNY
-0.50
(-2.46%)
0.18EPS
178.45P/E
2.83BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7.29
9.48
5.62
5.82
5.85
6.71
8.41
10.26
10.53
6.14
5.86
6.51
7.19
Basic EPS, GAAP
0.15
0.67
0.58
0.22
0.33
0.72
1.21
1.09
1.85
0.66
0.16
0.13
0.15
Free Cash Flow per Basic Share
-0.19
0.66
0.79
0.65
0.18
0.76
-0.36
1.32
-0.75
-0.49
-3.07
-0.42
- -
Dividend per Share
- -
0.32
0.22
0.37
0.07
0.11
0.22
0.02
0.25
0.38
0.2
0.12
0.03
Book Value per Share
0.59
1.53
1.65
2.31
2.78
3.16
4.18
5.25
12.16
12.44
12.41
12.43
12.53
Tangible Book Value per Share
0.45
1.36
1.46
2.14
2.37
2.76
3.1
4.2
11.39
11.66
11.62
11.66
11.79
Basic Weighted Avg Shares
47
47
70
76
81
81
81
81
99
108
108
107
106
Sales/Revenue/Turnover
341
448
393
443
477
546
680
833
1,041
662
632
693
765
Operating Margin (%)
3.62
8.75
14.21
8.16
6.49
14.78
20.06
14.48
17.25
9.44
1.34
1.97
3.2
Depreciation Expense
8
12
15
15
17
17
20
22
31
30
35
43
- -
Net Income, GAAP
7
32
41
17
27
59
98
89
183
71
17
14
16
Effective Tax Rate (%)
26.13
18.86
17.82
15.14
14.29
15.52
14.07
12.28
12.61
12.72
12.56
5.11
3.38
Profit Margin (%)
2.06
7.07
10.32
3.78
5.64
10.72
14.38
10.63
17.57
10.74
2.73
2
2.04
Working Capital
-84
-20
-7
57
65
76
61
66
877
693
439
313
256
LT Debt
- -
- -
- -
- -
- -
- -
30
- -
- -
- -
- -
- -
- -
Total Equity
48
137
144
193
233
269
363
454
1,345
1,376
1,371
1,372
1,386
Return on Invested Capital (%)
- -
32.83
24.4
9.52
12.6
25.43
31.76
20.43
21
5.25
1.17
1.22
1.41
Return on Capital (%)
- -
25.92
19.8
6.75
14.39
22.69
26.23
17.87
19.06
5.17
1.39
0.82
0.85
Return on Common Equity (%)
- -
37.02
31.52
10.43
13.03
24.33
32.9
23.17
21.04
5.35
1.29
1.03
1.15

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
8
16
10
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
108
108
108
Market Capitalization
2,883
2,522
2,826

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
671
676
632
Cash, Cash Equivalents & STI
247
235
232
Accounts Receivable, Net
117
96
91
Inventories
90
114
103
Total Current Liabilities
355
391
376
Payables & Accruals
- -
- -
- -
ST Debt
8
16
10
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.37%
44.7%
0.08%
Free Cash Flow
-6.07%
-45.7%
-86.6%
Net Income, GAAP
15.53%
-11.87%
-19.74%
Sales/Revenue/Turnover
6.33%
3.26%
9.63%
Total Cash Common Dividend
137.97%
245.46%
-39.15%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
135
166
128
204
632
2025
177
166
- -
187
693
2026
186
221
170
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.08
-0.03
0.03
0.16
2025
0.1
0.06
- -
0.01
0.13
2026
0.06
0.12
-0.05
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.2
- -
- -
0.2
2025
- -
0.06
- -
- -
0.12
2026
- -
0.03
- -
- -
- -

Company Description

CEO
Kuai Yu
Full Time Employees
434
Sector
Process industries
Industry
Chemicals: specialty
Address
Linhai China
IPO Date
Apr 19, 2022
Business
Zhejiang Realsun Chemical Co., Ltd. is a China-based company primarily engaged in the research, development, production, and distribution of specialty fine chemicals, pharmaceutical intermediates, agrochemical intermediates, and electronic chemical materials. Founded in 2007 and headquartered in Linhai, Zhejiang Province, China, the company operates advanced production bases and research facilities supplying customers across domestic and international markets, including Europe, North America, and other regions in Asia. The company's core product portfolio encompasses cyclopropane derivatives, including cyclopropanecarbonyl chloride, cyclopropanecarboxylic acid, cyclopropyl methyl ketone, and cyclopropylamine; butyryl and isobutyryl derivatives, including isobutyryl chloride and isobutyric anhydride; pyrrolidone and lactone series chemicals, including gamma-butyrolactone (GBL), N-methyl-2-pyrrolidone (NMP), and 2-pyrrolidone derivatives; boron trifluoride complexes and specialized Lewis acid catalysts; high-purity pharmaceutical intermediates for antiviral, antibacterial, oncology, cardiovascular, and central nervous system drug therapies; active agrochemical intermediates applied in novel fungicides, herbicides, and insecticides; electronic-grade specialty solvents and functional additives for electronic manufacturing; and custom synthesis and contract development and manufacturing organization (CDMO) services for global chemical and life sciences enterprises. In recent developments, Zhejiang Realsun Chemical has advanced the construction and commissioning of high-end fine chemical and electronic chemical manufacturing capacities, expanded continuous flow and micro-channel reaction technologies across its production lines to enhance operational efficiency and environmental compliance, diversified its product pipeline into high-purity electronic chemicals, and strengthened strategic supply chain collaborations with leading multinational pharmaceutical and agrochemical corporations.